Dr. Dayan Goodenowe Announces FDA Clinical Development Program for a Novel Alzheimer’s Therapeutic
TEMECULA, CALIFORNIA , UNITED STATES, February 10, 2026 /EINPresswire.com/ -- Dr. Dayan Goodenowe, author of Breaking Alzheimer’s, will present a formal FDA clinical development and validation pathway for a novel Alzheimer’s therapeutic program based on …